BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 28316213)

  • 21. High expression of long non-coding RNA lncRNA-ATB is correlated with metastases and promotes cell migration and invasion in renal cell carcinoma.
    Xiong J; Liu Y; Jiang L; Zeng Y; Tang W
    Jpn J Clin Oncol; 2016 Apr; 46(4):378-84. PubMed ID: 26848077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
    Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
    J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LASP1 Induces Epithelial-Mesenchymal Transition in Lung Cancer through the TGF-
    Xue Q; Jiang H; Wang J; Wei D
    Can Respir J; 2021; 2021():5277409. PubMed ID: 34912481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).
    Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
    Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of silencing LASP1 on biological behaviors of oral squamous cell carcinoma cells and IC50 of three anti-tumor drugs].
    Chen Q; Wang X; Yu YC; Wei KJ
    Shanghai Kou Qiang Yi Xue; 2019 Feb; 28(1):13-19. PubMed ID: 31080993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LASP1 in Tumor and Tumor Microenvironment.
    Hu Z; Wang X; Cui Y; Li C; Wang S
    Curr Mol Med; 2017; 17(8):541-548. PubMed ID: 29473505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
    Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
    J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.
    Nishikawa R; Goto Y; Sakamoto S; Chiyomaru T; Enokida H; Kojima S; Kinoshita T; Yamamoto N; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2014 Jul; 105(7):802-11. PubMed ID: 24815849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
    Sui Y; Zhang X; Yang H; Wei W; Wang M
    Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer.
    Yang F; Zhou X; Du S; Zhao Y; Ren W; Deng Q; Wang F; Yuan J
    PLoS One; 2014; 9(6):e100557. PubMed ID: 24955835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition.
    Wang B; Zhang L; Zhao L; Zhou R; Ding Y; Li G; Zhao L
    Cell Commun Signal; 2017 Jun; 15(1):21. PubMed ID: 28606091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of NSD2 Suppresses Renal Cell Carcinoma Metastasis by Inhibiting Epithelial-Mesenchymal Transition.
    Han X; Piao L; Yuan X; Wang L; Liu Z; He X
    Int J Med Sci; 2019; 16(10):1404-1411. PubMed ID: 31692936
    [No Abstract]   [Full Text] [Related]  

  • 36. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
    Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
    Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA Lnc01614 promotes the occurrence and development of gastric cancer by activating EMT pathway.
    Dong Y; Wang ZG; Chi TS
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1307-1314. PubMed ID: 29565488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.
    Orth MF; Cazes A; Butt E; Grunewald TG
    Oncotarget; 2015 Jan; 6(1):26-42. PubMed ID: 25622104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tim-3 facilitates osteosarcoma proliferation and metastasis through the NF-κB pathway and epithelial-mesenchymal transition.
    Feng ZM; Guo SM
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
    Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.